Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Lupus Erythematosus, Lupus Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01342016
What this trial is testing

Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients

Who this might be right for
Lupus Nephritis
Astellas Pharma Inc 84
Not applicableUnknownNCT02403115
What this trial is testing

Prediction of Outcome of Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Istituto Giannina Gaslini 800
Testing effectiveness (Phase 2)Study completedNCT00094380
What this trial is testing

Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)Ended earlyNCT00089804
What this trial is testing

Study of LJP 394 in Lupus Patients With History of Renal Disease

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
La Jolla Pharmaceutical Company 943
Early research (Phase 1)Study completedNCT03174587
What this trial is testing

Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Corestemchemon, Inc. 7
Not applicableNot Yet RecruitingNCT06654024
What this trial is testing

Urinary Congophilia as an Indicator of Activity of Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Assiut University 74
Not applicableLooking for participantsNCT07175285
What this trial is testing

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Bristol-Myers Squibb 223
Post-approval studies (Phase 4)Looking for participantsNCT05207358
What this trial is testing

Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis

Who this might be right for
Lupus Nephritis
Institutul Clinic Fundeni 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07729826
What this trial is testing

C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard Therapy

Who this might be right for
Lupus Nephritis (LN)Systemic Lupus Erythematosus (SLE)Autoimmune Diseases
AbelZeta Inc. 50
Large-scale testing (Phase 3)Ended earlyNCT05962788
What this trial is testing

Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis

Who this might be right for
Adolescent Lupus NephritisPediatric Lupus Nephritis
Aurinia Pharmaceuticals Inc. 4
Not applicableStudy completedNCT07031674
What this trial is testing

Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.

Who this might be right for
Lupus NephritisBelimumab
Yipeng Liu 56
Early research (Phase 1)WithdrawnNCT06752876
What this trial is testing

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP)

Who this might be right for
Systemic Lupus ErythematosusLupusLupus Erythematosus+1 more
Caribou Biosciences, Inc.
Post-approval studies (Phase 4)Ended earlyNCT03920059
What this trial is testing

Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Chulalongkorn University 2
Early research (Phase 1)Study completedNCT04128579
What this trial is testing

Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

Who this might be right for
Lupus ErythematosusLupus Nephritis
Biocon Limited 52
Large-scale testing (Phase 3)Study completedNCT02256150
What this trial is testing

Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Asahi Kasei Therapeutics Corporation 250
Testing effectiveness (Phase 2)UnknownNCT00659217
What this trial is testing

Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis

Who this might be right for
Lupus Nephritis
Organ Transplant Institute, China 20
Post-approval studies (Phase 4)UnknownNCT03214731
What this trial is testing

Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Sun Yat-sen University 90
Not applicableNot Yet RecruitingNCT07721857
What this trial is testing

Neutrophil Extracellular Traps and Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Assiut University 100
Large-scale testing (Phase 3)UnknownNCT01646736
What this trial is testing

Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis

Who this might be right for
Nephritis, Lupus
Peking Union Medical College Hospital 130
Large-scale testing (Phase 3)Ended earlyNCT00368264
What this trial is testing

TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Medical University of Vienna 1
Next Page